Xaprila Uses, Dosage, Side Effects and more
Xaprila is a low-to-moderate affinity uncompetitive NMDA receptor antagonist.
Xaprila is similar to memantine and acetylcholinesterase inhibitors in that neramexane targets the cognitive decline in Alzheimer’s Disease by altering neurotransmitter signaling, but not the underlying pathological mechanisms that cause the disease (amyloid production or neurofibrillary tangle accumulation).
| Attribute | Details |
|---|---|
| Trade Name | Xaprila |
| Generic | Neramexane |
| Neramexane Other Names | Neramexane |
| Type | |
| Formula | C11H23N |
| Weight | Average: 169.307 Monoisotopic: 169.183049741 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in alzheimer's disease, hearing loss, and pain (acute or chronic).
How Xaprila works
Xaprila is an uncompetitive NMDA receptor channel blocker.
